Wells Fargo has suspended all travel to China after an employee was barred from leaving, adding to a trend of foreign executives facing probes that has dampened business sentiment. A Japanese Astellas Pharma employee was sentenced to 3.5 years for spying. Chinese authorities released Mintz Group employees detained in Beijing two years ago. AstraZeneca’s China president was detained and under investigation, suspected of fabricating genetic testing results and insurance fraud. Nomura Holdings banker Charles Wang Zhonghe was ordered not to leave China. UBS wealth manager in China was prevented from leaving in 2018.

Read more at Yahoo Finance: Factbox-Foreign firms’ executives entangled in Chinese probes